Hippel James 4

Accession 0001062993-25-013359

CIK 0000842023other

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 4:28 PM ET

Size

26.8 KB

Accession

0001062993-25-013359

Form 4

Period: 2025-07-29

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-07-29$44.33/sh+168,620$7,474,925→ 275,230 total
Exercise/Conversion
Stock Options (Right to Buy)
2025-07-29−168,620→ 0 total
Exercise: $44.33Exp: 2025-08-08→ Common Stock (168,620 underlying)
Tax Payment
Common Stock
2025-07-29$58.55/sh−147,431$8,632,085→ 127,799 total

Holdings

Stock Options (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (40,536 underlying)
40,536
Performance Restricted Stock Units
→ Common Stock (13,865 underlying)
13,865
Restricted Stock Units
→ Common Stock (13,159 underlying)
13,159
Restricted Stock Units
→ Common Stock (34,634 underlying)
34,634
Stock Options (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (186,068 underlying)
186,068
Performance Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (33,916 underlying)
33,916
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (37,314 underlying)
37,314
Performance Restricted Stock Units
→ Common Stock (24,062 underlying)
24,062
Restricted Stock Units
→ Common Stock (12,031 underlying)
12,031
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (167,328 underlying)
167,328
Performance Restricted Stock Units
→ Common Stock (10,912 underlying)
10,912
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (45,220 underlying)
45,220
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (45,923 underlying)
45,923
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (32,417 underlying)
32,417

Footnotes (12)

[F1]Fully exercisable.
[F10]4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
[F11]Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
[F12]11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
[F2]Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
[F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
[F4]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F5]Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
[F6]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F7]Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
[F8]13,159 restricted stock units vest on 11/1/2025.
[F9]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother